51³Ô¹ÏÍø
Tag - novartis
Subscribe
Digital
Print
July 25, 2026
Subscribe
Digital
Print
Heat
Parliament
China
Latest News
Home Delivery
51³Ô¹ÏÍø
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
NOVARTIS
BUSINESS
/
Markets
Apr 1, 2026
Drugmakers delay some European launches with a wary eye on Trump¡¯s pricing policies
The White House has been pushing to lower the cost of prescription drugs in the U.S., which has traditionally paid significantly more than other wealthy countries.
BUSINESS
/
Companies
Jan 10, 2024
Swiss pharma firms plot different paths to blockbuster drugs
Roche has doubled down on Alzheimer¡¯s and boosted research and development spending across its portfolio.
WORLD
/
Science & Health
Jun 3, 2023
Breast cancer drug shown to reduce recurrence risk
Even when the disease is caught early, breast cancer recurrence is relatively common ¡ª and for survivors, the prospect can be daunting.
BUSINESS
/
Companies
Nov 25, 2019
Novartis agrees to buy Medicines Co. in $6.8 billion deal targeting promising cholesterol drug
Novartis AG agreed to buy Medicines Co. for an equity value of about $6.8 billion, snapping up a promising cholesterol drug and adding to a string of acquisitions for Chief Executive Officer Vas Narasimhan.
BUSINESS
Aug 8, 2019
Novartis says it knew of Zolgensma data problems before U.S. approval
Swiss Drugmaker Novartis AG on Wednesday said it knew about discrepancies in data it submitted to regulators as it sought approval of its more than $2 million gene therapy Zolgensma, but delayed notifying authorities until it completed an internal investigation.
BUSINESS
May 10, 2018
Novartis ends contract with firm linked to Trump lawyer Michael Cohen, calling ties a mistake
Swiss drugmaker Novartis has ended a contract with a firm linked to U.S. President Donald Trump¡¯s lawyer, Michael Cohen, saying it was now seen as a mistake.
51³Ô¹ÏÍø
/
Science & Health
/
A MATTER OF HEALTH
Nov 15, 2017
Japanese doctor who exposed a drug too good to be true calls for morality and reforms
It was a gut feeling and common sense that made Dr. Iwao Kuwajima question a drug for high blood pressure that just about every other doctor in his field was excited about in the 2000s.
BUSINESS
Sep 11, 2017
Novartis posts win, Roche a flop in drug trials targeting skin cancer
Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche with slipping sales failed in a separate study with a similar patient group.
WORLD
/
Science & Health
Jul 9, 2015
Progress reported in using gene therapy for deafness
Gene therapy for deafness is moving closer to reality, with new research on Wednesday showing the technique for fixing faulty DNA can improve responses in mice with genetic hearing loss.
EDITORIALS
Jul 28, 2013
Question of objectivity
A Kyoto university¡¯s announcement that research on blood-pressure drug Diovan was manipulated raises concerns about the drugmaker¡¯s objectivity.
COMMENTARY
/
World
Apr 22, 2013
Markets flunk challenge of poor people¡¯s health
A lack of balance exists between the health needs of really poor people in the world and the market for helping the rich and super-rich lead a fashionable lifestyle.
WHAT¡¯S TRENDING
Editors' Picks
Japan weighs regulating Pokemon cards amid trading mania
Japan to set up expert working group on accepting foreign nationals
Head of Swiss euthanasia firm dies after collapsing while ascending Mount Fuji
Indian brothers make manga debut in Japan
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
Japan to set up expert working group on accepting foreign nationals
Inside Toho Archive¡¯s mission to save Japan¡¯s cinematic memory
The sci-fi sensibilities of electronic trio Black Boboi
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By
Alex K.T. Martin
SUSTAINABLE 51³Ô¹ÏÍø
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER